Iodine-131 (I-131) is a radiopharmaceutical that can be used for diagnostic and therapeutic purposes. Therapeutic purpose includes treatment of thyroid malignancy in a postoperative patient and hyperthyroidism. This article summarizes thyroid malignancies, anatomy and physiology of the thyroid gland, indications and contraindications of radioactive iodine treatment for thyroid malignancy, patient preparation for treatment, and possible treatment complications. Well-differentiated thyroid carcinomas respond well to I-131 therapy. The activity highlights the role of the interprofessional healthcare team in patient evaluation and treatment for better clinical outcomes.

**Objectives:**
- Describe the mechanism of action of RAI in the treatment of thyroid malignancies.
- Outline RAI treatment indications and contraindications in thyroid cancers.
- Explain the patient's preparation for RAI treatment in thyroid cancer.
- Identify the significance of efficient coordination and shared decision-making between interprofessional healthcare team members for a better outcome.